QC Kinetix Names Bart Bess as Chief Operating Officer
Philadelphia-area franchise owner transitions to new executive roleCHARLOTTE, NC / ACCESSWIRE / November 7, 2023 / QC Kinetix, a fast-growing...
Philadelphia-area franchise owner transitions to new executive roleCHARLOTTE, NC / ACCESSWIRE / November 7, 2023 / QC Kinetix, a fast-growing...
CAMBRIDGE, MA / ACCESSWIRE / November 7, 2023 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one...
TARRYTOWN, NY / ACCESSWIRE / November 7, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for...
Care Oncology Partners with WellnessScript to Offer Mental Health support to cancer patientsTORONTO, ON / ACCESSWIRE / November 7, 2023...
Shipment marks the first batch of Psychedelic molecules explicitly for the Authorized Prescriber SchemeVANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE...
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced it has submitted a 510(k) premarket notification to the...
Additional Exclusive License with NCSU Further Expands Reduced Nicotine Content Plant Breeding CapabilitiesBUFFALO, N.Y., Nov. 07, 2023 (GLOBE NEWSWIRE) --...
Cannabix has developed a contactless alcohol breathalyzer for employers and vehicles Cannabix Technologies Inc. Figure 1 Cannabix Contactless Alcohol Breathalyzer...
LAWRENCEVILLE, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated...
CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
CARLSBAD, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing...
FDA briefing included new Ewing sarcoma clinical data from ongoing investigation where 60% of first-relapse patients achieved disease control and...
– Patient recruitment underway in ENERGY-3 Pivotal Trial of INZ-701 in pediatric patients with ENPP1 Deficiency; topline data expected mid-2025...
BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused on developing novel, orally bioavailable...
PGX processing unit with a 10X (100 L) vessel capacity to be installed and tested at NATEX pilot testing facility...
Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the...
Denver, Colorado--(Newsfile Corp. - November 7, 2023) - Last week, the CBD of Denver, Inc.'s (OTC Pink: CBDD), Luxora team...
Oakville, Ontario--(Newsfile Corp. - November 7, 2023) - FendX Technologies Inc. (CSE:FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX")...
Scientist, inventor, business expert, and holder of more than 140 patents will bring forward PUR Biologics' regenerative therapeutic patent portfolio...
DUBLIN, IRELAND / ACCESSWIRE / November 7, 2023 / Nemysis is pleased to announce receipt of grant funding under the...